Derek M Meisner has sold stock and made no open-market buys since Sep 2020
GC, Corp Sec at Acumen Pharmaceuticals, Inc., and 1 other company
SEC CIK 0001752461 · Filings on SEC.gov ↗
Companies
Every filing
9 filings since Sep 2020, newest first
Acumen Pharmaceuticals, Inc.
GC, Corp Sec
Acumen Pharmaceuticals, Inc.
GC, Corp Sec
Acumen Pharmaceuticals, Inc.
GC, Corp Sec
Acumen Pharmaceuticals, Inc.
GC, Corp Sec
Acumen Pharmaceuticals, Inc.
GC, Corp Sec
X4 Pharmaceuticals, Inc
General Counsel
X4 Pharmaceuticals, Inc
General Counsel
X4 Pharmaceuticals, Inc
General Counsel
X4 Pharmaceuticals, Inc
General Counsel
About Derek M Meisner
Derek M. Meisner is the Chief Legal Officer and Corporate Secretary at Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing treatments for Alzheimer's disease.( He joined Acumen in 2022, bringing over two decades of legal experience in regulatory compliance, financings, mergers and acquisitions, strategic partnerships, and corporate governance for public and private companies.(
Prior to Acumen, Meisner held similar roles at X4 Pharmaceuticals, Inc. (as General Counsel) and Genocea Biosciences, Inc. (as Senior VP and General Counsel).( Earlier, he served as General Counsel for Boston-based financial services firms, including RA Capital Management, was a partner at K&L Gates, and worked as a Branch Chief in the U.S. Securities and Exchange Commission's Division of Enforcement.( As of early 2026, he owns approximately 83,800 shares of ABOS following recent sales under a Rule 10b5-1 plan totaling $91,073.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.